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1. Introduction 
Biologically active peptides, like substance P [ 1 ] , 
somatostatin [2] , enkephalins [3] , the C-terminal 
octapeptide of pancreozymin [4,5] and vasoactive 
intestinal polypeptide (VIP) [6,7] have been found 
in several discrete areas of the mammalian brain. More 
specifically, their concentration and localization in 
nerve endings suggest a possible involvement in neuro- 
transmission. VIP, found essentially in the cortical 
gray matter and in the hypothalamus, has been 
detected chiefly in the synaptosomal fraction - which 
also contains dopamine - during subcellular fractiona- 
tions [8] . A further argument in favor of VIPs sus- 
pected role in neurotransmission would be the detec- 
tion of biological activity at the cerebral cell level. 
As VIP is a potent activator of an adenylate cyclase 
from both liver [9] and pancreas [lo] , we tested the 
hypothesis that VIP could also activate a brain adenyl- 
ate cyclase. This paper demonstrates that VIP activates 
an adenylate cyclase from a synaptosomal fraction of 
guinea pig brain. This activation was not potentiated 
by guanyl triphosphate nucleotides, and was unaffected 
by (IL- and @-adrenergic blockers and by atropine. 
Furthermore, peptides related to VIP, like secretin, 
glucagon and somatostatin, were devoid of significant 
agonistic or antagonistic activity. EGTA was also with- 
out effect on basal and VIP-stimulated activities while 
calcium at concentrations higher than lo-’ M inhibited 
both activities. 
2. Materials and methods 
2.1. Brain membrane preparation 
For each preparation, two adult female guinea pigs 
were killed by decapitation and the brains, weighing 
approx. 3 g, were homogenized in 30 ml ice-cold 0.32 
M sucrose, using a glass homogenizer with a Teflon 
pestle. Subcellular fractionation was conducted by 
a modification of the Whittaker procedure [ 111. The 
homogenate was centrifuged at 1000 X g for 10 min. 
The supernatant was centrifuged at 12 000 X g for 
20 min. The resulting pellet was resuspended in 15 ml 
of ice-cold distilled water, rehomogenized, and then 
diluted with an equal volume of a 25 mM Tris-HCl 
buffer, pH 7.4, containing 1 mM 2-mercaptoethanol 
and 2 mM MgClz. This suspension, 5 ml as layered on 
a discontinuous density gradient consisting of 5 ml 
aliquots of, respectively, 0.4 M, 0.6 M, 0.8 M, 1.0 M 
and 1.2 M sucrose, and centrifuged for 2 h at 25 000 
rev/min in a rotor SW 27 in a Beckman Model L 
ultracentrifuge. The interfaces were collected, diluted 
in 20 vol. the abovementioned buffer and centrifuged 
at 50 000 X g for 30 min. The pellets, rehomogenized 
in the same buffer, were stored in liquid nitrogen and 
were stable for at least 3 weeks. The present data 
were obtained on the material collected at the 1 .O M 
- 1.2 M sucrose interface, which exhibited the highest 
adenylate cyclase activity. 
2.2. Adenylate cyclase activity 
Adenylate cyclase activity was determined accord- 
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ing to Salomon et al. [12] . The standard adenylate 
cyclase reaction mixture (final vol. 60 fi) contained 
the following final concentrations: 30 mM Tris-HCl 
(pH 7.4), 5 mM MgC12, 0.5 mM EGTA, 1 mM cyclic 
AMP, 1 mM theophylline, 0.5 mM [w~~P]ATP, 10 
mM phospho(enol)pyruvate and 30 pg/ml pyruvate 
kinase. In all the test conditions, the kinetics remained 
linear for at least 9 min at 37°C. 
2.3.Protein estimation 
Proteins were estimated by the method of Lowry 
et al. [ 131 using bovine serum albumin as the standard. 
3. Results 
VIP- activated adenylate cyclase of a guinea pig 
synaptosomal fraction in a dose-dependent manner. 
The concentration giving half-maximal stimulation 
! 
E 
0 1 
ii 0 to-8 IO-7 IO-6 IO-5 
VIP (Ml 
Fig.1. Dose-response curve of adenylate cyclase activation of 
a guinea pig brain synaptosomal fraction in presence of 
increasing concentrations of VIP. The results obtained in the 
standard assay conditions (7 min incubation at 37°C) are 
presented as increases in cyclic AMP over the basal value 
(189 + 12 pmol/min/mg protein) and are the mean * SEM 
of 6 determinations. 
was approximately 5 X lo-’ M. The maximal VIP- 
stimulated cyclic AMP production was a 2.2-fold 
increase of the basal enzyme activity (fig.1). 
The two guanyl triphosphate nucleotides, GTP 
and guanosine S’@,y-imido)triphosphate (Gpp(NH)p), 
were potent activators of this brain adenylate cyclase 
but did not potentiate VIP stimulation. At any VIP 
concentration, the effect of a nearly maximal concen- 
tration of both nucleotides was purely additive (fig.2). 
Furthermore, the dose-response curves of each nucleo- 
tide in the absence or presence of a submaximal 10” M 
VIP concentration were almost parallel (fig.3). 
The VIP-stimulated adenylate cyclase appeared 
highly specific as it was not influenced by either an 
a-adrenergic blocker (phentolamine), a /3-adrenergic 
blocker (propranolol) or a muscarinic inhibitor (atro- 
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Fig.2. Dose-response curves of VIP-stimulated adenylate 
cyclase activity of a guinea pig brain synaptosomal fraction 
in absence (o-o) and presence of 10‘” M GTP (A-A) 
or 10v5 M Gpp(NH)p (m-m). The results obtained in the 
standard assay conditions (7 min incubation at 37°C) are the 
mean of three experiments. 
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Fig.3. Dose-response curves of guanyl triphosphate nucleo- 
tide-stimulated adenylate cyclase activity of a guinea pig 
synaptosomal fraction in absence (open symbols) or presence 
(closed symbols) of 1Om6 M VIP. The results for GTP (o,*) 
and Gpp(NH)p (a,~) are the mean of three experiments. 
pine), Furthermore, the hormonal peptides possessing 
structural similarities with VIP (secretin, glucagon and 
somatostatin) were devoid of any significant effect on 
basal or VIP-stimulated adenylate cyclase (table 1). 
EGTA 0.5 mM moderately decreased the basal 
value but did not modify the VIP-stimulated activity. 
On the contrary, it systematically enhanced the stimu- 
lation by Gpp(NH)p. In the absence of EGTA, calcium 
at micromolar concentrations had no influence on 
either basal, guanyl triphosphate nucleotide- and VIP- 
stimulated adenylate cyclase. At concentrations higher 
than lo-’ M, calcium appeared to be an inhibitor of 
all kinds of adenylate cyclase activations (fig.4). 
4. Discussion 
Among the putative neurotransmitters of the 
central nervous system, some are thought to act via 
Table 1 
Effects of phentolamine, propranolol, atropine and peptides of 
the secretin family on basal and VIP-stimulated adenylate cyclase 
Drug or 
peptide 
Adenylate cyclase activity 
(pmol formed/min/mg protein) 
Basal + 1O-6 M VIP 
Control 190 389 
Phentolamine 1O-3 M 190 382 
Propranolol lo-’ M 179 412 
Atropine lo-” M 171 350 
Secretin 10“ M 195 392 
Glucagon lo-’ M 183 378 
Somatostatin 1O-5 M 164 347 
Incubations were performed under standard conditions 
(37”C, 7 min incubation) and the results are the mean of two 
experiments made in duplicate 
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Fig.4. Effect of 0.5 mM EGTA (closed symbols) and increas- 
ing concentrations of calcium (open symbols) on basal (o,o); 
3.10m6 M VIP (0,m); and 3.10-’ M Gpp(NH)p (A+) stimulated 
adenylate cyclase of a guinea pig brain synaptosomal fraction. 
The results are the mean of three experiments. 
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adenylate cyclase activation. This is the case for bio- 
genie amines like norepinephrine, dopamine, serotonin 
and histamine [ 141 , although these substances do not 
always perfectly satisfy Sutherland’s four essential 
criteria [ 151 . The recently discovered brain peptides 
have been less extensively studied and only substance 
P has been reported to activate a particulate brain 
adenylate cyclase [ 161 . 
Our results clearly demonstrate that VIP must be 
added to the list of the brain substances activating an 
adenylate cyclase in brain extract. 
With respect to adenylate cyclase activation, there 
were two main differences between brain VIP receptors 
and the VIP receptors of mammalian liver, pancreas 
and adipose tissue: 
Brain receptors were highly specific: they did not 
recognize the parent hormones, glucagon and 
secretin. Brain VIP-stimulated adenylate cyclase, 
like the VIP-stimulated enzyme from rat liver [9] , 
guinea pig pancreas [ 171 and rat adipose tissue 
[18] was not influenced by glucagon. But, the latter 
tissues are in fact influenced by secretin: guinea pig 
pancreatic acinar cells, for example, possess two 
distinct VIP receptor sites coupled with an adenyl- 
ate cyclase, both of which are occupied to variable 
degrees by secretin [ 171. The VIP-sensitive brain 
adenylate cyclase, however, remained unaffected 
by secretin. 
Somatostatin can be considered as a secretin- 
family peptide analog on the basis of a common 
tetrapeptide sequence [19]. Here again, somato- 
statin was a partial agonist of secretin-induced cyclic 
AMP accumulation in rat pancreas fragments [ 191 , 
and had no effect on the brain VIP-sensitive 
adenylate cyclase. 
Brain VIP-sensitive adenylate cyclase was not 
potentiated by guanyl triphosphate nucleotides: 
in contrast to liver [20] and pancreas [21], the 
effect of GTP and Gpp(NH)p on VIP-stimulated 
enzyme were purely additive, suggesting an indepen- 
dence of the hormonal and guanyl nucleotides sites. 
In some brain adenylate cyclase preparations, 
calcium is reported to be an activator of the basal 
adenylate cyclase activity at low concentrations and 
to be an inhibitor at higher concentrations [22] . In 
our preparation, low micromolar calcium concentra- 
tions were without effect but concentrations higher 
than lo-’ M were inhibitory on basal, guanyl triphos- 
phate nucleotide- and VIP-stimulated activity. Similar 
findings have been described for histamine-stimulated 
adenylate cyclase in guinea pig brain [23] . 
In conclusion, the presence of a highly specific 
VIP-sensitive adenylate cyclase in a guinea pig synapto- 
somal fraction supports the concept that the VIP 
present in brain cortical synaptosomes could be a 
neurotransmitter in the mammalian brain. 
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